Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02115542
Title Single Agent Regorafenib in Refractory Advanced Biliary Cancers
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Indications

bile duct carcinoma

gallbladder carcinoma

Therapies

Regorafenib

Age Groups: adult
Covered Countries USA


No variant requirements are available.